GFAP and pituitary tumor: By using a transgenic over expression model, we show that GFAP-Cre mediated transgenic over expression of Bmi1 is sufficient to drive the formation of pituitary tumors, a type of tumor that represents 10 to 25% of all intracranial neoplasms in humans.